Cecilie Fremstad Rustad

Cecilie Fremstad Rustad

Auto-generated profile, based on publicly available information

Cecilie Fremstad Rustad

Centre for Rare Disorders, Oslo University Hospital, Oslo, Norway

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2019 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
DDDavid A. Dyment
David A. Dyment
PTPaulien A. Terhal
Paulien A. Terhal
CRCecilie F. Rustad
Cecilie F. Rustad
TTTveten Tveten
Tveten Tveten
CGChristopher Griffith
Christopher Griffith
MLMatthew A. Lines
Matthew A. Lines
The developmental and epileptic encephalopathies (DEE) are a heterogeneous group of chronic encephalopathies frequently associated with rare de novo nonsynonymous coding variants in neuronally expressed genes. Here, we describe eight probands with a DEE phenotype comprising intellectual disability, epilepsy, and hypotonia. Exome trio analysis showed de novo variants in TRPM3, encoding a brain-expressed transient receptor potential channel, in each. Seven probands were identically heterozygous for a recurrent substitution, p.(Val837Met), in TRPM3’s S4–S5 linker region, a conserved domain proposed to undergo conformational change during gated channel opening. The eighth individual was heterozygous for a proline substitution, p.(Pro937Gln), at the boundary between TRPM3’s flexible pore-forming loop and an adjacent alpha-helix. General-population truncating variants and microdeletions occur throughout TRPM3, suggesting a pathomechanism other than simple haploinsufficiency. We conclude that de novo variants in TRPM3 are a cause of intellectual disability and epilepsy.

16 July 2019 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
LBLucy Bownass
Lucy Bownass
SAStephen Abbs
Stephen Abbs
RARuth Armstrong
Ruth Armstrong
GBGenevieve Baujat
Genevieve Baujat
GBGry Behzadi
Gry Behzadi
SSSarah Smithson
Sarah Smithson

12 May 2021 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
CRCecilie F. Rustad
Cecilie F. Rustad
KTKristian Tveten
Kristian Tveten
TPTrine E. Prescott
Trine E. Prescott
PBPeder O. Bjerkeseth
Peder O. Bjerkeseth
CBCecilie Bredrup
Cecilie Bredrup
HPHelle Cecilie Viekilde Pfeiffer
Helle Cecilie Viekilde Pfeiffer

22 November 2023 in npj Genomic Medicine
Verified
Journal Article
Open access
PDF file
PJPrince Jacob
Prince Jacob
HLHillevi Lindelöf
Hillevi Lindelöf
CRCecilie F. Rustad
Cecilie F. Rustad
VSVernon Reid Sutton
Vernon Reid Sutton
SMShahida Moosa
Shahida Moosa
GGGiedre Grigelioniene
Giedre Grigelioniene
Spondyloepimetaphyseal dysplasia with severe short stature, RPL13-related (SEMD-RPL13), MIM#618728), is a rare autosomal dominant disorder characterized by short stature and skeletal changes such as mild spondylar and epimetaphyseal dysplasia affecting primarily the lower limbs. The genetic cause was first reported in 2019 by Le Caignec et al., and six disease-causing variants in the gene coding for a ribosomal protein, RPL13 (NM_000977.3) have been identified to date. This study presents clinical and radiographic data from 12 affected individuals aged 2–64 years from seven unrelated families, showing highly variable manifestations. The affected individuals showed a range from mild to severe short stature, retaining the same radiographic pattern of spondylar- and epi-metaphyseal dysplasia, but with varying severity of the hip and knee deformities. Two new missense variants, c.548 G>A, p.(Arg183His) and c.569 G>T, p.(Arg190Leu), and a previously known splice variant c.477+1G>A were identified, confirming mutational clustering in a highly specific RNA binding motif. Structural analysis and interpretation of the variants’ impact on the protein suggests that disruption of extra-ribosomal functions of the protein through binding of mRNA may play a role in the skeletal phenotype of SEMD-RPL13. In addition, we present gonadal and somatic mosaicism for the condition.

12 August 2022 in American Journal of Medical Genetics Part A
Verified
Journal Article
Open access
CRCecilie F. Rustad
Cecilie F. Rustad
TPTrine E. Prescott
Trine E. Prescott
EMElse Merckoll
Else Merckoll
EKErle Kristensen
Erle Kristensen
CSCathrin L. Salvador
Cathrin L. Salvador
KTKristian Tveten
Kristian Tveten

22 April 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
CRCecilie Fremstad Rustad
Cecilie Fremstad Rustad
RBRagnheidur Bragadottir
Ragnheidur Bragadottir
HNHilde Nordgarden
Hilde Nordgarden
JMJeanette Ullmann Ullmann Miller
Jeanette Ullmann Ullmann Miller
MWMina Susanne Weedon-Fekjær
Mina Susanne Weedon-Fekjær
SSSolrun Sigurdardottir
Solrun Sigurdardottir
Objectives This study aimed to determine healthcare needs and care use (provision of healthcare) in adults with Bardet–Biedl syndrome (BBS) and the associations between care use and physical functioning, health status outcomes and distress. Design Cross-sectional study. Setting Outpatient hospital visits. Participants 30 adults with BBS were included (50% women, aged 20–69 years) and assessed with the Needs and Provision Complexity Scale, Short Physical Performance Battery, EuroQoL five dimensions with five severity levels (EQ-5D-5L) and Hospital Anxiety and Depression Scale. Results The majority (80%) received disability benefits, 93% were overweight or obese and all had retinal dystrophy. Unmet needs (needs-gets) were found within the domains of rehabilitation (83%), social and family support (63%), healthcare (50%), personal care (47%) and the environment (40%). Significant correlations were observed between care use (gets) and worse physical performance (τ=−0.34, p<0.05), more problems with self-care (τ=0.47, p<0.01) and more problems with usual activities (τ=0.41, p=0.01). Compared with those in the general population, adults with BBS reported significantly more problems (EQ-5D-5L) with mobility, self-care, and usual activities (all p<0.001). Conclusions Most adults with BBS have unmet physical, social and medical needs, with the majority having unmet rehabilitation needs that require special attention. Physical mobility and usual activities were correlated with the provision of healthcare. The complexity of BBS requires a multidisciplinary approach that focuses not only on the medical follow-up of the condition but also on healthcare needs for functional mobility and social care. Trial registration number This study was registered at ClinicalTrials.gov, NCT05400278.